States’ Control Of Prescription Drug Spending: A Heterogeneous Approach
Authors:
- 1 July 2005
- journal article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 24 (4) , 1032-1038
Abstract
In an effort to balance Medicaid budgets, states use prescription drug cost containment tools in unique ways and in varying combinations. We report on the variability in state-level strategies to control the cost of prescription drugs and describe broad state-to-state differences in per beneficiary spending on drugs. This heterogeneity raises the question of appropriate state program variability. Research is needed to determine the medically, ethically, and legally most suitable means of controlling drug costs, especially as the Medicare Part D drug plan will likely recapitulate the prescription drug program variability observed among the states.Keywords
This publication has 7 references indexed in Scilit:
- The Pharmaceutical Industry versus Medicaid — Limits on State Initiatives to Control Prescription-Drug CostsNew England Journal of Medicine, 2004
- Access Versus Excess: Value-Based Cost Sharing For Prescription DrugsHealth Affairs, 2004
- Evidence-Based And Value-Based Formulary GuidelinesHealth Affairs, 2004
- Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In MedicaidHealth Affairs, 2004
- How Much Should Medicare Pay For Drugs?Health Affairs, 2004
- Hospital Use and Survival among Veterans Affairs BeneficiariesNew England Journal of Medicine, 2003
- The Prescription as Final Common PathwayInternational Journal of Technology Assessment in Health Care, 1995